Toxicoepigenetics on histones using mass spectrometry

02:573 years ago

Toxicoepigenetics is an emerging field that studies the toxicological impact of compounds on protein expression through heritable, non-genetic mechanisms, such as histone post-translational modifications (hPTMs). Due to substantial progress in the large-scale study of hPTMs, integration into the field of toxicology is promising and offers the opportunity to gain novel insights into toxicological phenomena. Moreover, there is a growing demand for high-throughput human-based in vitro assays for toxicity testing, especially for developmental toxicity. Consequently, we developed a mass spectrometry-based proof-of-concept to assess a histone code screening assay capable of simultaneously detecting multiple hPTM-changes in human embryonic stem cells. To prove the applicability and performance, we first validated the untargeted workflow with valproic acid (VPA), a histone deacetylase inhibitor. These results demonstrate that our workflow is capable of mapping the hPTM-dynamics, with a general increase in acetylations as an internal control. To illustrate the scalability, a dose-response study was performed on a proof-of-concept library of ten compounds i) with a known effect on the hPTMs (BIX-01294, 3-Deazaneplanocin A, Trichostatin A, and VPA), ii) classified as highly embryotoxic by the European Centre for the Validation of Alternative Methods (ECVAM) (Methotrexate, and All-trans retinoic acid), iii) classified as non-embryotoxic by ECVAM (Penicillin G), and iv) compounds of abuse with presumed developmental toxicity (ethanol, caffeine, and nicotine). In conclusion, we show that toxicoepigenetic screening on histones is feasible and yields very rich data that can contribute to the (safe) development of drugs and holds potential, not only for applications in the pharmaceutical industry, but also for environmental toxicity and food safety.

Lab website: https://www.progentomics.ugent.be/
Linkedin: https://www.linkedin.com/in/sigrid-verhelst-a54798172/
ResearchGate: https://www.researchgate.net/profile/Sigrid-Verhelst

Related

AI agents for safer science: How AI is Changing Chemical Risk Assessment
Innovation examples
HealthToxicologyIn silico

AI agents for safer science: How AI is Changing Chemical Risk Assessment

This video introduces a novel approach to chemical safety, where intelligent digital agents guided by large language models support scientists in making faster, more transparent decisions. By automating complex workflows and integrating tools like the OECD QSAR Toolbox, these agentic systems help prioritise research, reduce reliance on animal testing, and pave the way for safer, more sustainable innovation.
02:563 days ago
User Research in developing the virtual human platform
Innovation examples
ToxicologyPolicy

User Research in developing the virtual human platform

Digital tools can support the phasing out of animal-based tests and data in chemical risk assessment. This is one of the core promises of the Virtual Human Platform. The potential contribution of digitalization is linked to the acceptance and adoption of tools, methods, and data by stakeholders in several societal sectors. To facilitate the integration of stakeholders in the configuration of digital tools, Dr. Isaac Ortega Alvarado and colleagues gather insights from risk assessors in their role as users. Risk assessors are the ones who actualize chemical risk assessment and its standards through their practices. With this perspective, this research contributes to understanding the development and implementation of digital tools as embedded in social processes of construction and reception.
01:1525 days ago
Pro tips for making a video about your research
TPI.tv videos
Beginner

Pro tips for making a video about your research

Need some pro-tips to make your next video on animal-free innovations? Aniek and Victoria got some for you! In this video, they share why you should want to make a video about your research, tips about the content and format of an attractive video, and how to best share your video.
03:2525 days ago
NXTGEN Hightech Biomed
Projects and initiatives
HealthInnovationIn vitroOrgan-on-Chip

NXTGEN Hightech Biomed

The Netherlands has strong academic knowledge in areas like Lab-on-Chip, Organ-on-Chip, artificial organs, and cell production technology. However, turning this knowledge into actual products is challenging due to the need for collaboration between different technological and biological specialists. The NXTGEN Hightech program (https://nxtgenhightech.nl/en/biomed/) addresses this by creating a collaborative environment where companies from various fields work together. This approach aims to transform academic insights into innovative products, benefiting both the industry and society.
02:1726 days ago